John Newby is the CEO of Virginia Bio, the nonprofit statewide trade association that serves and promotes the life sciences industry in Virginia.
Eric Arocho is associate vice president at Eli Lilly and Company and the site lead on the company’s facility in Goochland County, Virginia - announced last year. The Goochland facility, expected to be completed within the next five years, will produce both critical drug components and finished medicines to support Lilly’s emerging bioconjugate platform and monoclonal antibody portfolio.
Pam Cheng is executive vice president of global operations and IT and chief sustainability officer at AstraZeneca, which recently announced a new facility in Albemarle County — the company’s first in Virginia. VEDP Vice President of Manufacturing Sneha Atwal spoke with Cheng about the Commonwealth’s rapid rise in pharmaceutical engineering and the company’s plans for the new facility.
Virginia’s pharma manufacturing successes build on years of ecosystem development.
Across Virginia, local life sciences ecosystems are helping researchers connect with the funding and facilities they need to grow.
Virginia’s cities, counties, and towns represent a wide range of living situations, with a location to support any lifestyle.
The pharmaceutical manufacturing innovation that came out of a Virginia university is changing the way medicines are made. The Commonwealth’s universities and the rest of its biopharma research community are making sure Virginia is ready to make the medicines of the future.
Virginia’s cities, counties, and towns represent a wide range of living situations, with a location to support any lifestyle.
Best Medical International, a Virginia-based cancer treatment manufacturer, is expanding its global reach with support from VEDP. The Commonwealth's strategic logistics advantages and targeted international outreach continue to position Best Medical for sustained global growth.
Investments from Virginia Tech, Carilion support critical studies in brain, heart, and cancer issues.